W. L. Gore & Associates, Inc. Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft
11/20/2013 9:38:44 AM
FLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced the launch of the GORE ACUSEAL Vascular Graft for vascular access. Designed for early cannulation within 24 hours after implantation, the GORE ACUSEAL Vascular Graft expands treatment options for earlier removal or possible avoidance of a central venous catheter – a major source of infection for hemodialysis patients. The Food and Drug Administration (FDA) cleared the GORE ACUSEAL Vascular Graft in April 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by